209 related articles for article (PubMed ID: 34792719)
1. Antibiotic Susceptibility of Staphylococcus aureus Plankton and Biofilm Forms Isolated in Implant-Associated Infection.
Babushkina IV; Mamonova IA; Ulyanov VY; Gladkova EV; Shpinyak SP
Bull Exp Biol Med; 2021 Nov; 172(1):46-48. PubMed ID: 34792719
[TBL] [Abstract][Full Text] [Related]
2. Resistance to Antibiotics in Plankton and Biofilm Cultures of Pseudomonas aeruginosa Clinical Strains.
Babushkina IV; Mamonova IА; Ulyanov VY; Gladkova ЕV; Shpinyak SP
Bull Exp Biol Med; 2021 Dec; 172(2):155-157. PubMed ID: 34853964
[TBL] [Abstract][Full Text] [Related]
3. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antibiotic treatment of implant-associated
Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
7. Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
Nair S; Desai S; Poonacha N; Vipra A; Sharma U
Antimicrob Agents Chemother; 2016 Dec; 60(12):7280-7289. PubMed ID: 27671070
[TBL] [Abstract][Full Text] [Related]
8. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308
[TBL] [Abstract][Full Text] [Related]
10. Bacteria Colonizing the Ocular Surface in Eyes With Boston Type 1 Keratoprosthesis: Analysis of Biofilm-Forming Capability and Vancomycin Tolerance.
Jassim SH; Sivaraman KR; Jimenez JC; Jaboori AH; Federle MJ; de la Cruz J; Cortina MS
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4689-96. PubMed ID: 26207304
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-tolerant Staphylococcus aureus Biofilm Persists on Arthroplasty Materials.
Urish KL; DeMuth PW; Kwan BW; Craft DW; Ma D; Haider H; Tuan RS; Wood TK; Davis CM
Clin Orthop Relat Res; 2016 Jul; 474(7):1649-56. PubMed ID: 26831479
[TBL] [Abstract][Full Text] [Related]
12. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Activity of the Quinoline Derivative HT61 against Staphylococcus aureus Biofilms.
Frapwell CJ; Skipp PJ; Howlin RP; Angus EM; Hu Y; Coates ARM; Allan RN; Webb JS
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122902
[No Abstract] [Full Text] [Related]
14. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
15. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of Staphylococcus aureus biofilms.
Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
[TBL] [Abstract][Full Text] [Related]
19. A modified chronic infection model for testing treatment of Staphylococcus aureus biofilms on implants.
Jørgensen NP; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
PLoS One; 2014; 9(10):e103688. PubMed ID: 25279456
[TBL] [Abstract][Full Text] [Related]
20. MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis.
Girard LP; Ceri H; Gibb AP; Olson M; Sepandj F
Perit Dial Int; 2010; 30(6):652-6. PubMed ID: 21148059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
